RNA-binding proteins and cancer metastasis

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• RNA-binding proteins (RBPs) regulate gene expression post-transcriptionally, impacting mRNA, miRNA, and circRNA processing.
• Dysregulation of RBPs is linked to various human diseases, notably cancer, influencing phenotypes like proliferation and migration.
• Tumor metastasis is a major cause of cancer mortality, necessitating elucidation of its underlying molecular mechanisms.

Purpose of the Study:

• To review recent advances in understanding the role of RBPs in tumor metastasis.
• To discuss how RBP dysfunctions affect metastasis-associated processes like EMT, migration, and invasion.
• To explore emerging RBP-based therapeutic strategies for combating cancer metastasis.

Main Methods:

• Literature review of recent research on RBPs and cancer metastasis.
• Analysis of RBP involvement in epithelial-mesenchymal transition (EMT), cell migration, and invasion.
• Synthesis of current knowledge on RBP-based treatment strategies.

Main Results:

• RBPs significantly influence cancer cell phenotypes crucial for metastasis.
• Specific RBPs are identified as key players in promoting or inhibiting metastasis-associated processes.
• Dysregulation of RBPs contributes to tumor progression and poor clinical prognosis.

Conclusions:

• RBPs are critical regulators of cancer metastasis.
• Targeting RBPs offers promising therapeutic avenues for cancer treatment.
• Further research into RBP functions is essential for developing effective anti-metastasis strategies.